Time-Restricted Eating and Mindfulness-Based Stress Reduction to Reduce the Risk of Early-Onset Colorectal Cancer
NCT ID: NCT06022887
Last Updated: 2024-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
43 participants
INTERVENTIONAL
2023-10-18
2024-07-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Is it feasible and acceptable to conduct 8-week remote interventions of TRE, MBSR, and combined TRE+MBSR among young adults with excess adiposity and moderate-to-severe perceived stress?
* Will participants in the combined group lose more body weight and reduce their stress levels than those in the remaining groups?
* Will participants in the combined group experience better body composition changes and improve their cardiometabolic health compared to those in the remaining groups?
* Will participants in the combined group exhibit changes in the microbiome compared to those in the remaining groups?
Participants will:
* Complete 8 weeks of a TRE intervention
* Complete 8 weeks of a remote MBSR intervention
Researchers will compare 1. TRE alone; 2. MBSR alone; 3. TRE + MBSR; and 4. Control to see if the study is feasible and acceptable; to see if individuals lose body weight; to see if individual stress levels reduce; to see changes in the microbiome.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Targeting Chronic Stress for Reducing Risk Factors for Colorectal Cancer
NCT06323421
Reducing Metabolic Dysregulation in Dyads
NCT06117241
Health Behaviors in Patients Who Have Finished Treatment for Stage I, Stage II, or Stage III Colorectal Cancer
NCT00966667
Personalized Health Self-Management Training for Colorectal Cancer Survivors
NCT05984589
Online Mindfulness-Based Intervention to Decrease Pre-Procedural Anxiety Before a First-Time Screening Colonoscopy
NCT06233253
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
The control group will not receive any of the interventions previously described. To maintain a relationship with each participant in the control group, we will contact them once a week via text message to engage them to finalize the intervention period. At the end of the intervention period and after all data is collected, the RD will meet with the participant for 30 minutes and will educate them regarding the TRE protocol and provide access to the MBSR web-based program.
No interventions assigned to this group
TRE alone
Participants will be instructed to eat ad libitum from noon - 8:00pm daily and fast from 8:00pm - noon (16-h fast) for 8 weeks. During the 8-h eating window, there will be no restrictions on types or quantities of foods consumed. Participants will meet with a registered dietitian (RD) for 30 minutes at the start of the intervention to review instructions and goals and weekly thereafter. Adherence to the TRE intervention will be assessed as the number of adherent days per week.
TRE
daily ad libitum food intake, 8-h 12pm - 8pm, 8 wks active weight loss phase;
MBSR alone
Participants in this study will be granted access to a remote mindfulness-based stress reductions (MBSR) protocol. Participants will have access to the MBSR course, consisting of 30 audio lessons, each ranging from 9 to 14 minutes long. During the study, participants will be asked to complete four lessons per week during weeks 1-7 and two lessons during week 8.
MBSR
Completed 30 sessions of a Mindfulness-Based Stress Reduction (MBSR) interventions for 8 weeks
TRE + MBSR
This group will follow a combined protocol of the TRE and MBSR interventions as described above.
TRE
daily ad libitum food intake, 8-h 12pm - 8pm, 8 wks active weight loss phase;
MBSR
Completed 30 sessions of a Mindfulness-Based Stress Reduction (MBSR) interventions for 8 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TRE
daily ad libitum food intake, 8-h 12pm - 8pm, 8 wks active weight loss phase;
MBSR
Completed 30 sessions of a Mindfulness-Based Stress Reduction (MBSR) interventions for 8 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. BMI 30-49.99 kg/m2.
3. Own and use a smartphone, computer, or tablet with access to the Internet.
4. Score ≥ 14 on the Perceived Stress Score (PSS) at screening.
Exclusion Criteria
2. Have taken antibiotics in the previous 2 months.
3. Have an inflammatory bowel disease or genetic predisposition to EOCRC or CRC (e.g., Lynch syndrome);.
4. Any cancer diagnosis or cancer treatment in the past 12 months.
5. Consume \>50 grams ethanol daily (approximately 4-5, 12 ounces beers).
6. Use combustible tobacco.
7. Have history of bariatric surgery or bowel resection.
8. Have an active infection.
9. Have type 1 or type 2 diabetes, immunodeficiency/autoimmune disorder, or inflammatory bowel disease.
10. Use fiber or pre-/probiotic supplements \>3 days per week.
11. Currently taking corticosteroids medication - inhaled, topical, or oral in the past 2 months (affects cortisol measures).
12. Are on a weight-loss diet or involved in a formal weight-loss program or are not weight stable for 3 months (+/- 4.5 kg) prior to the study.
13. Females who are pregnant/trying to become pregnant.
14. Have schizophrenia (medication can affect study outcomes).
15. Have an eating window of \<10 hours/day or are currently following an intermittent fasting pattern.
16. Night shift workers (shift passes midnight).
17. Present a history of eating disorder.
18. Currently taking weight loss medication.
19. Illegal drug use in the past month (not marijuana).
18 Years
39 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Illinois at Chicago
OTHER
Lisa Tussing-Humphreys
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lisa Tussing-Humphreys
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Manoela Lima Oliveira, MS, RD, LDN
Role: PRINCIPAL_INVESTIGATOR
PhD Candidate
Lisa M Tussing-Humphreys, PHD, RD
Role: PRINCIPAL_INVESTIGATOR
Associate Professor, Kinesiology and Nutrition
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Applied Health Sciences Building - University of Illinois at Chicago
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Sinicrope FA. Increasing Incidence of Early-Onset Colorectal Cancer. N Engl J Med. 2022 Apr 21;386(16):1547-1558. doi: 10.1056/NEJMra2200869. No abstract available.
Doubeni CA, Major JM, Laiyemo AO, Schootman M, Zauber AG, Hollenbeck AR, Sinha R, Allison J. Contribution of behavioral risk factors and obesity to socioeconomic differences in colorectal cancer incidence. J Natl Cancer Inst. 2012 Sep 19;104(18):1353-62. doi: 10.1093/jnci/djs346. Epub 2012 Sep 5.
Related Links
Access external resources that provide additional context or updates about the study.
If you are interested in this research, please answer some eligibility questions in the survey linked here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY2023-0498
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.